• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型α1肾上腺素能受体拮抗剂JTH-601对人前列腺的亲和力比对动脉的亲和力高10倍以上。

New alpha1-adrenoceptor antagonist, JTH-601, shows more than 10 times higher affinity for human prostates than arteries.

作者信息

Takahashi M, Taniguchi T, Murata S, Okada K, Moriyama N, Yamazaki S, Muramatsu I

机构信息

Department of Pharmacology, School of Medicine, Fukui Medical University, Matsuoka, Japan.

出版信息

J Urol. 1999 Apr;161(4):1350-4.

PMID:10081906
Abstract

PURPOSE

We compared the affinities of a new alpha1-adrenoceptor (AR) antagonist, JTH-601 with those of several alpha1-AR antagonists in human prostates and arteries.

RESULTS

In the functional study, noradrenaline produced concentration-dependent contractions in human prostates and mesenteric arteries. The pA2/pKB values for the antagonists in the human prostate were 9.78 for tamsulosin, 8.84 for JTH-601, 8.39 for WB4101, 8.23 for prazosin, 8.12 for JTH-601-G1 (a main metabolite of JTH-601 in human) and 6.57 for BMY7378. Compared these affinities with those in the mesenteric artery, only JTH-601 and JTH-601-G1 exhibited unique uroselectivity, showing 10- to 20-fold higher affinity for the human prostate than for mesenteric artery. The affinity profile of these antagonists suggested that the noradrenaline-induced contractions in the human prostate and the mesenteric artery were mediated by the alpha1L-AR and alpha1B-AR, respectively. In the competition binding study, the pharmacological profiles of the antagonists against [3H]-prazosin were examined in the human prostate and aorta. The resulting pKi values for JTH-601 and JTH-601-G1 were also approximately 10- to 20-fold higher for the human prostate than for the human aorta.

CONCLUSION

These results have suggested that JTH-601 and JTH-601-G1 are unique uroselective alpha1-AR antagonists that show higher affinity for the human prostate than for the human arteries.

摘要

目的

我们比较了新型α1肾上腺素能受体(AR)拮抗剂JTH - 601与几种α1 - AR拮抗剂在人前列腺和动脉中的亲和力。

结果

在功能研究中,去甲肾上腺素在人前列腺和肠系膜动脉中产生浓度依赖性收缩。在人前列腺中,拮抗剂的pA2/pKB值分别为:坦索罗辛9.78、JTH - 601 8.84、WB4101 8.39、哌唑嗪8.23、JTH - 601 - G1(JTH - 601在人体内的主要代谢产物)8.12、BMY7378 6.57。将这些亲和力与肠系膜动脉中的进行比较,只有JTH - 601和JTH - 601 - G1表现出独特的尿选择性,对人前列腺的亲和力比对肠系膜动脉高10至20倍。这些拮抗剂的亲和力谱表明,去甲肾上腺素在人前列腺和肠系膜动脉中诱导的收缩分别由α1L - AR和α1B - AR介导。在竞争结合研究中,在人前列腺和主动脉中检测了拮抗剂对[3H] - 哌唑嗪的药理学谱。JTH - 601和JTH - 601 - G1在人前列腺中的所得pKi值也比对人主动脉高约10至20倍。

结论

这些结果表明,JTH - 601和JTH - 601 - G1是独特的尿选择性α1 - AR拮抗剂,对人前列腺的亲和力高于对人动脉的亲和力。

相似文献

1
New alpha1-adrenoceptor antagonist, JTH-601, shows more than 10 times higher affinity for human prostates than arteries.新型α1肾上腺素能受体拮抗剂JTH-601对人前列腺的亲和力比对动脉的亲和力高10倍以上。
J Urol. 1999 Apr;161(4):1350-4.
2
Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues.JTH-601及其代谢产物在大鼠组织中的分布及α(1)-肾上腺素能受体结合特性
Drug Metab Dispos. 2000 Dec;28(12):1487-92.
3
Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates.新型α1-肾上腺素能受体拮抗剂[3H]-JTH-601的药理学特性:与重组人α1-肾上腺素能受体及人前列腺的结合
Life Sci. 2000 Oct 6;67(20):2443-51. doi: 10.1016/s0024-3205(00)00826-2.
4
Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.新型选择性α1-肾上腺素能受体拮抗剂KMD-3213的药理学分析及其作为氚标记放射性配体的适用性
Br J Pharmacol. 1999 May;127(1):19-26. doi: 10.1038/sj.bjp.0702489.
5
Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.兔虹膜中α1-肾上腺素能受体的评估:药理学特性及mRNA表达
Br J Pharmacol. 1999 Jul;127(6):1367-74. doi: 10.1038/sj.bjp.0702675.
6
Prostate selectivity of JTH-601-G1, an active metabolite of JTH-601, in dogs.JTH-601的活性代谢产物JTH-601-G1在犬体内的前列腺选择性
BJU Int. 2000 Mar;85(4):542-50. doi: 10.1046/j.1464-410x.2000.00443.x.
7
Tissue selectivity of KMD-3213, an alpha(1)-adrenoreceptor antagonist, in human prostate and vasculature.α1肾上腺素能受体拮抗剂KMD-3213在人前列腺和血管中的组织选择性
J Urol. 2000 Aug;164(2):578-83.
8
Comparison of prazosin, terazosin and tamsulosin: functional and binding studies in isolated prostatic and vascular human tissues.哌唑嗪、特拉唑嗪和坦索罗辛的比较:人离体前列腺组织和血管组织的功能及结合研究
Prostate. 2001 Jun 1;47(4):231-8. doi: 10.1002/pros.1067.
9
Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery.新型下尿路选择性α-1拮抗剂Rec 15/2739对去甲肾上腺素诱导的人前列腺和肠系膜动脉收缩的功能拮抗活性。
J Pharmacol Exp Ther. 1996 Jun;277(3):1237-46.
10
Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.新型α1L-肾上腺素能受体拮抗剂JTH-601在大鼠组织中的体外和体内α1-肾上腺素能受体结合特性
Biol Pharm Bull. 1999 Jul;22(7):687-90. doi: 10.1248/bpb.22.687.

引用本文的文献

1
Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.兔虹膜中α1-肾上腺素能受体的评估:药理学特性及mRNA表达
Br J Pharmacol. 1999 Jul;127(6):1367-74. doi: 10.1038/sj.bjp.0702675.